Skip to main content
. 2021 Jun 29;8:704691. doi: 10.3389/fnut.2021.704691

Table 1.

Subject characteristics.

Characteristic All subjects (n = 47) GDS 1-3 (n = 23) GDS 4–7 (n = 24) P-valuea
Age in years, mean (SD) 102.2 (2.5) 102.2 (2.3) 102.2 (2.8) 0.946
Female, n (%) 42 (89%) 19 (83%) 23 (96%) 0.188
Race, n (%) 0.348
  Caucasian 42 (89%) 22 (96%) 20 (83%)
  Black 5 (11%) 1 (4%) 4 (17%)
BMI in kg/m2, mean (SD)b 22.1 (3.9) 23.1 (3.5) 21.0 (4.0) 0.067
Hypertension, n (%) 25 (53%) 12 (52%) 13 (54%) 1
Diabetes, n (%) 3 (6%) 2 (9%) 1 (4%) 0.609
Education, n (%) 0.204
   < High school 23 (51%) 9 (39%) 14 (64%)
  High school 12 (27%) 7 (30%) 5 (23%)
  > High school 10 (22%) 7 (30%) 3 (14%)
  No data 2 0 2
Living, n (%) 0.212
  Community dwelling 14 (30%) 9 (39%) 5 (21%)
  Institutionalized 33 (70%) 14 (61%) 19 (79%)
Dietary supplement use, n (%) 34 (72%) 14 (61%) 20 (83%) 0.111
Medications, n (%)
  Antidepressants 14 (30%) 4 (17%) 10 (42%) 0.111
  Antipsychotics 5 (12%) 1 (4%) 4 (17%) 0.348
  Anti-inflammatory medications 5 (12%) 4 (17%) 1 (4%) 0.188
  Antithrombotics 10 (21%) 5 (22%) 5 (21%) 1
  Antibiotics 7 (15%) 2 (9%) 5 (21%) 0.416
Smoking, n (%) 0.570
  Never 30 (86%) 18 (86%) 12 (86%)
  Past 4 (11%) 3 (14%) 1 (7%)
  Present 1 (3%) 0 (0%) 1 (7%)
  No data 12 2 10
Alcohol use, n (%) 0.041
  Never 21 (60%) 9 (43%) 12 (86%)
  Past 6 (17%) 5 (24%) 1 (7%)
  Present 8 (23%) 7 (33%) 1 (7%)
  No data 12 2 10
APOE, n (%)c
  ε2 allele carrier 8 (17%) 3 (13%) 5 (21%) 0.701
  ε4 allele carrier 8 (17%) 3 (13%) 5 (21%) 0.701
a

Comparisons between subjects whose Global Deterioration Scale (GDS) = 1–3 (non-demented) and GDS = 4–7 (demented) using Student's t-test for continuous variables and Fisher's exact test for categorical variables.

b

Body mass index (BMI) cannot be calculated for a double amputee whose GDS = 5.

c

All subjects who carried an ε2 or ε4 allele were ε2/ε3 or ε3/ε4 except one subject with GDS = 4 who was an ε2/ε4.